Associations between the Expression of Mucins (MUC1, MUC2, MUC5AC, and MUC6) and Clinicopathologic Parameters of Human Breast Ductal Carcinomas
Open Access
- 1 January 2013
- journal article
- Published by Korean Breast Cancer Society in Journal of Breast Cancer
- Vol. 16 (2), 152-158
- https://doi.org/10.4048/jbc.2013.16.2.152
Abstract
Mucins are members of the glycoprotein family expressed in benign and malignant epithelial cells. The aim of this study is to evaluate the relationships between the expression of mucins in breast ductal carcinoma and clinicopathologic parameters. We constructed tumor microarrays based on 240 cases of invasive ductal carcinoma and 40 cases of ductal carcinoma in situ (DCIS) using formalin fixed, paraffin embedded tissues. We examined the expressions of MUC1, MUC2, MUC5AC, and MUC6 by immunohistochemistry. MUC1 demonstrated cytoplasmic, membranous, apical, and combinative expressions. Other mucins demonstrated cytoplasmic expression. In invasive ductal carcinoma, MUC1, MUC2, MUC5AC, and MUC6 were expressed in 93.6%, 6.2%, 4.8%, and 12.4% of cases, respectively; these rates were slightly, but not significantly, higher than observed in cases of DCIS. MUC1 expression was associated with estrogen receptor (ER) expression and negative MUC1 expression was associated with triple negativity. MUC6 expression was correlated with higher histologic grade, lymphatic invasion, lymph node metastasis, and HER2 positivity. No associations with any other clinicopathologic parameters were observed. Most invasive ductal carcinomas of the breast express MUC1, and this expression is associated with ER expression. MUC6 expression is correlated with some clinicopathologic parameters that are indicators of poor prognosis. To evaluate the role of MUC6 as a potential biomarker, further studies are warranted.Keywords
This publication has 27 references indexed in Scilit:
- Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologistsLaboratory Investigation, 2011
- MUC2 expression in primary mucinous and nonmucinous adenocarcinoma of the prostate: an analysis of 50 cases on radical prostatectomyLaboratory Investigation, 2008
- The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome of invasive ductal breast carcinomaHistopathology, 2007
- Pathogenesis of Colloid (Pure Mucinous) Carcinoma of Exocrine OrgansThe American Journal of Surgical Pathology, 2003
- Immunohistochemical study of the expression of MUC5AC and MUC6 in breast carcinomas and adjacent breast tissuesJournal of Clinical Pathology, 2001
- Polymorphism of the human MucgenesFrontiers in Bioscience-Landmark, 2001
- The epithelial mucin, MUC1, of milk, mammary gland and other tissuesBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1995
- Epithelial Mucin GenesAnnual Review of Physiology, 1995
- MUC6 apomucin shows a distinct normal tissue distribution that correlates with Lewis antigen expression in the human stomachGastroenterology, 1995
- Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components.The Journal of cell biology, 1995